GDERF — Galderma Group AG/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2021390 ·
Last close
$225.00
Market Cap
$52.47B
52W High
$248.46
52W Low
$193.40
ADV30
1,960
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 13,393,000,000 | 780,000,000 | 5,244,000,000 |
| Jun 2025 | — | — | — | — | 12,877,000,000 | 458,000,000 | 5,147,000,000 |
| Dec 2024 | — | — | — | — | 12,617,000,000 | 457,000,000 | 4,827,000,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$6,347,000,000
Inventory
$525,000,000
Receivables
—
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$5,240,999,936
EBITDA
$1,134,000,000
Free Cash Flow
$905,000,000
Enterprise Value
$54,751,961,088
Total Cash
$780,000,000
Total Debt
$2,753,999,872
Shares Out
233,188,937
Trailing EPS
$3.65
Book Value
$34.74
ROE
7.7%
ROA
4.3%
Div Yield
0.20%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,241,000,000 | 876,000,000 | 613,000,000 | 13,393,000,000 | 5,244,000,000 | — | 1,185,000,000 |
| Dec 2024 | 4,440,000,000 | 678,000,000 | 231,000,000 | 12,617,000,000 | 4,827,000,000 | — | 488,000,000 |
| Dec 2023 | 4,117,000,000 | 611,000,000 | -57,000,000 | 12,471,000,000 | 7,102,000,000 | — | 165,000,000 |
| Dec 2022 | 3,823,900,000 | 406,000,000 | -98,500,000 | — | — | — | 111,300,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CTVA | Corteva, Inc. | $52.64B | $78.71 | — |
| LHX | L3HARRIS TECHNOLOGIES, INC. /DE/ | $51.59B | $277.06 | — |
| ROK | ROCKWELL AUTOMATION, INC | $53.42B | $480.08 | — |
| COHR | COHERENT CORP. | $51.43B | $262.89 | — |
| GALDY | Galderma Group AG/ADR | $50.84B | $43.60 | — |
News headlines (Yahoo Finance, 1h cache)
Morgan Stanley bullish on Galderma on stronger Nemluvio growth outlook
2026-07-30 13:29 · Yahoo
Galderma Group AG (GDERF) Half Year 2026 Earnings Call Highlights: Record Sales and Strategic ...
2026-07-23 19:00 · Yahoo
Galderma Reports Record First Half 2026 Net Sales of 3.134 Billion USD and 24.6% Year-on-Year Growth at Constant Currency, Raises Net Sales Guidance for the Full Year
2026-07-23 05:00 · Yahoo
Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region
2026-07-20 05:00 · Yahoo
Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns
2026-07-07 05:00 · Yahoo
Galderma falls after FDA issues second setback for Botox rival
2026-07-01 08:08 · Yahoo
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States
2026-07-01 05:00 · Yahoo
Is Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year?
2026-06-16 13:40 · Yahoo
What Makes Galderma Group AG - Unsponsored ADR (GALDY) a New Strong Buy Stock
2026-05-05 16:00 · Yahoo
European Market Insights 3 Stocks Estimated Below Fair Value
2026-04-29 10:37 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.